Most Popular Angioplasty Web Site
New Terumo Glidecath® Catheter Yashiro Tip Shape Improves Access to Celiac Artery
Features Uniquely-Shaped Three Dimensional Tip Design
February 13, 2008 -- Somerset, New Jersey -- Terumo Interventional Systems’ proven Glidecath Hydrophilic Coated catheter product line makes way for the Yashiro tip shape; a new, three-dimensional U-shape tip for optimal entry to the celiac trunk.

Terumo Interventional Systems, a strategic business unit of Terumo Medical Corporation, has extended its Glidecath line of catheters to offer the new Yashiro tip shape, which provides better access to certain arteries, particularly the celiac artery. When rotating the catheter counterclockwise, the distal end can be easily manipulated to enter the ostium of the celiac artery.

In trials, doctors have noted that the tip “pops right in,” which makes the Glidecath’s Yashiro tip shape ideal for most liver-related procedures. Also, unlike other catheters, when the tip enters the celiac trunk, the three-dimensional shape provides a stable entry platform.

The Glidecath’s Yashiro tip shape is available in 4 Fr and 5 Fr size catheters that are 70 cm in length. These catheters are packaged three per box.

For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800-862-4143 or by visiting

Terumo Interventional Systems
Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists and Vascular Surgeons are among the medical professionals that depend upon TIS products to access and cross difficult-to-reach lesions thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of needles and syringes, entry-site management products and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with $2.3 billion in sales and operations in more than 150 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP) and is a component of the Nikkei 225, Japan’s leading stock index.

Source: Terumo Interventional Systems